Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2015

01.09.2015

The experience of cognitive change in women with breast cancer following chemotherapy

verfasst von: Mary Louise Kanaskie, Susan J. Loeb

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Change in cognitive function is one side effect of chemotherapy reported in some breast cancer survivors sometimes years after treatment. These symptoms include subtle changes in memory, concentration, and executive functioning. The purpose of this study was to uncover the meaning of cognitive change in women with breast cancer, how symptoms are experienced and become evident, how symptoms impact roles in personal and professional lives, and how women cope with these changes.

Methods

An interpretive phenomenological study was conducted with seven women with breast cancer, between the ages of 42–59, who had completed standard chemotherapy treatment within the past 12 months. Participants completed two in-depth semistructured interviews 1 month apart and maintained a written journal.

Results

van Manen’s framework for interpretive phenomenology revealed five essential themes: noticing the difference, experiencing cognitive changes, interacting socially, coping, and looking forward. Analysis also includes a description of the phenomenon in relation to the lifeworld existentials of lived space, lived body, lived time, and lived human relation.

Conclusions

The experience of cognitive change could not be isolated or studied separately from the context of the women’s reality of having breast cancer.

Implications for Cancer Survivors

This study provides clarity related to the impact of cognitive change and how women cope with these changes in relation to their daily roles and responsibilities. Information is provided that elucidates the effect on employment issues that can influence financial and social well-being of women who are breast cancer survivors living with chemotherapy-related cognitive changes.
Literatur
2.
Zurück zum Zitat Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20(2):485–93.CrossRefPubMed Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20(2):485–93.CrossRefPubMed
3.
Zurück zum Zitat Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer a critical review. J Pain Symptom Manag. 2001;21(5):407–24.CrossRef Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer a critical review. J Pain Symptom Manag. 2001;21(5):407–24.CrossRef
4.
Zurück zum Zitat Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22(11):2233–9.CrossRefPubMed Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22(11):2233–9.CrossRefPubMed
5.
Zurück zum Zitat Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum. 2007;34(5):981–94.CrossRefPubMed Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum. 2007;34(5):981–94.CrossRefPubMed
6.
Zurück zum Zitat O’Shaughnessy J. Chemotherapy-related cognitive dysfunction in breast cancer. Semin Oncol Nurs. 2003;19(Supp2):17–24.CrossRefPubMed O’Shaughnessy J. Chemotherapy-related cognitive dysfunction in breast cancer. Semin Oncol Nurs. 2003;19(Supp2):17–24.CrossRefPubMed
8.
Zurück zum Zitat Falleti MG, Sanfilippo A, Maruff P, Weih LA, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005;59(1):60–70.CrossRefPubMed Falleti MG, Sanfilippo A, Maruff P, Weih LA, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005;59(1):60–70.CrossRefPubMed
9.
Zurück zum Zitat Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85(3):640–50.CrossRefPubMed Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85(3):640–50.CrossRefPubMed
10.
Zurück zum Zitat Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology. 2006;15(5):422–30.CrossRefPubMed Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology. 2006;15(5):422–30.CrossRefPubMed
11.
Zurück zum Zitat Boehmke MM, Dickerson SS. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nurs. 2005;28(5):382–9.CrossRefPubMed Boehmke MM, Dickerson SS. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nurs. 2005;28(5):382–9.CrossRefPubMed
12.
Zurück zum Zitat Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19(4):623–9.CrossRefPubMed Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19(4):623–9.CrossRefPubMed
13.
14.
Zurück zum Zitat Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock I. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho-Oncology. 2006;15(10):921–30.CrossRefPubMed Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock I. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho-Oncology. 2006;15(10):921–30.CrossRefPubMed
15.
Zurück zum Zitat Mitchell T. The social and emotional toll of chemotherapy—patients’ perspectives. Eur J Cancer Care. 2007;16(1):39–47.CrossRef Mitchell T. The social and emotional toll of chemotherapy—patients’ perspectives. Eur J Cancer Care. 2007;16(1):39–47.CrossRef
16.
Zurück zum Zitat Fitch MI, Armstrong J, Tsang S. Patients’ experiences with cognitive changes after chemotherapy. Can Oncol Nurs J. 2008;18(4):180–92.CrossRefPubMed Fitch MI, Armstrong J, Tsang S. Patients’ experiences with cognitive changes after chemotherapy. Can Oncol Nurs J. 2008;18(4):180–92.CrossRefPubMed
17.
Zurück zum Zitat Von Ah D, Russell KM, Storniolo AM, Carpenter JS. Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum. 2009;36(3):326–36.CrossRef Von Ah D, Russell KM, Storniolo AM, Carpenter JS. Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum. 2009;36(3):326–36.CrossRef
18.
Zurück zum Zitat Von Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013;17(2):236–41.CrossRef Von Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013;17(2):236–41.CrossRef
19.
20.
Zurück zum Zitat Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3(4):223–32.PubMedCentralCrossRefPubMed Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3(4):223–32.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Myers JS. Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum. 2012;39(1):E31–40.CrossRefPubMed Myers JS. Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum. 2012;39(1):E31–40.CrossRefPubMed
22.
Zurück zum Zitat van Manen M. Researching the lived experience—human science for an action pedagogy. Albany: State University of New York Press; 1990. van Manen M. Researching the lived experience—human science for an action pedagogy. Albany: State University of New York Press; 1990.
23.
Zurück zum Zitat Polit DF, Beck CT. Essentials of nursing research: methods, appraisal and utilization. Philadelphia: Lippincott, Williams & Wilkins; 2006. Polit DF, Beck CT. Essentials of nursing research: methods, appraisal and utilization. Philadelphia: Lippincott, Williams & Wilkins; 2006.
24.
Zurück zum Zitat Thorne S, Kirkham SR, MacDonald-Emes J. Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health. 1997;20(2):169–77.CrossRefPubMed Thorne S, Kirkham SR, MacDonald-Emes J. Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health. 1997;20(2):169–77.CrossRefPubMed
25.
Zurück zum Zitat Morse JM, Field PA. Qualitative research methods for health professionals. Thousand Oaks: Sage; 1995. Morse JM, Field PA. Qualitative research methods for health professionals. Thousand Oaks: Sage; 1995.
26.
Zurück zum Zitat Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills: Sage; 1995. Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills: Sage; 1995.
27.
Zurück zum Zitat Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum. 2005;32(6):1151–63.CrossRefPubMed Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum. 2005;32(6):1151–63.CrossRefPubMed
28.
Zurück zum Zitat Thorne SE, Stajduhar KI. Patient perceptions of communications on the threshold of cancer survivorship: implications for provider responses. J Cancer Surviv. 2012;6(2):229–37.CrossRefPubMed Thorne SE, Stajduhar KI. Patient perceptions of communications on the threshold of cancer survivorship: implications for provider responses. J Cancer Surviv. 2012;6(2):229–37.CrossRefPubMed
29.
Zurück zum Zitat Rosedale M, Fu MR. Confronting the unexpected: temporal, situational, and attributive dimensions of distressing symptom experience for breast cancer survivors. Oncol Nurs Forum. 2010;37(1):E28–33.CrossRefPubMed Rosedale M, Fu MR. Confronting the unexpected: temporal, situational, and attributive dimensions of distressing symptom experience for breast cancer survivors. Oncol Nurs Forum. 2010;37(1):E28–33.CrossRefPubMed
30.
Zurück zum Zitat Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nurs. 1993;16(2):83–92.CrossRefPubMed Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nurs. 1993;16(2):83–92.CrossRefPubMed
31.
Zurück zum Zitat Cimprich B, Ronis D. An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs. 2003;26(4):284–92.CrossRefPubMed Cimprich B, Ronis D. An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs. 2003;26(4):284–92.CrossRefPubMed
32.
Zurück zum Zitat Louiselle C, Rockhill J. Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction. Curr Pain Headache Rep. 2009;13(4):271–6.CrossRef Louiselle C, Rockhill J. Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction. Curr Pain Headache Rep. 2009;13(4):271–6.CrossRef
33.
Zurück zum Zitat Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer. 2004;100(11):2292–9.CrossRefPubMed Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer. 2004;100(11):2292–9.CrossRefPubMed
34.
Zurück zum Zitat Burger A. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum. 2009;36(4):E165–77.CrossRef Burger A. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum. 2009;36(4):E165–77.CrossRef
35.
36.
Zurück zum Zitat Kim HJ, Barsevick AM, Beck SL, Dudley W. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. Oncol Nurs Forum. 2012;39(1):E20–30.CrossRefPubMed Kim HJ, Barsevick AM, Beck SL, Dudley W. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. Oncol Nurs Forum. 2012;39(1):E20–30.CrossRefPubMed
37.
Zurück zum Zitat Matthews EE, Berger AM, Schmiege SJ, Cook PF, McCarthy MS, Moore CM, et al. Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. Oncol Nurs Forum. 2014;41(3):241–53.CrossRefPubMed Matthews EE, Berger AM, Schmiege SJ, Cook PF, McCarthy MS, Moore CM, et al. Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. Oncol Nurs Forum. 2014;41(3):241–53.CrossRefPubMed
38.
Zurück zum Zitat Kim HJ, McDermott PA, Barsevick AM. Comparison of groups with different patterns of symptom cluster intensity across the breast cancer trajectory. Cancer Nurs. 2014;37(2):88–96.PubMedCentralCrossRefPubMed Kim HJ, McDermott PA, Barsevick AM. Comparison of groups with different patterns of symptom cluster intensity across the breast cancer trajectory. Cancer Nurs. 2014;37(2):88–96.PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40(1):35–42.CrossRefPubMed Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40(1):35–42.CrossRefPubMed
40.
Zurück zum Zitat Barez M, Blasco T, Fernandez-Castro J, Viladrich C. Perceived control and psychological distress in women with breast cancer: a longitudinal study. J Behav Med. 2009;32(2):187–96.CrossRefPubMed Barez M, Blasco T, Fernandez-Castro J, Viladrich C. Perceived control and psychological distress in women with breast cancer: a longitudinal study. J Behav Med. 2009;32(2):187–96.CrossRefPubMed
41.
Zurück zum Zitat Schreiber JA. Image of God: effect on coping and psychospiritual outcomes in early breast cancer survivors. Oncol Nurs Forum. 2011;38(3):293–301.CrossRefPubMed Schreiber JA. Image of God: effect on coping and psychospiritual outcomes in early breast cancer survivors. Oncol Nurs Forum. 2011;38(3):293–301.CrossRefPubMed
42.
Zurück zum Zitat Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.CrossRefPubMed Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.CrossRefPubMed
43.
Zurück zum Zitat Lopez KA, Willis DG. Descriptive versus interpretive phenomenology: their contributions to nursing knowledge. Qual Health Res. 2004;14(5):726–35.CrossRefPubMed Lopez KA, Willis DG. Descriptive versus interpretive phenomenology: their contributions to nursing knowledge. Qual Health Res. 2004;14(5):726–35.CrossRefPubMed
44.
Zurück zum Zitat Player L, Mackenzie L, Willis K, Loh SY. Women’s experiences of cognitive changes or ‘chemobrain’ following treatment for breast cancer: a role for occupational therapy? Aust Occup Ther J. Online Feb 6, 2014. Player L, Mackenzie L, Willis K, Loh SY. Women’s experiences of cognitive changes or ‘chemobrain’ following treatment for breast cancer: a role for occupational therapy? Aust Occup Ther J. Online Feb 6, 2014.
Metadaten
Titel
The experience of cognitive change in women with breast cancer following chemotherapy
verfasst von
Mary Louise Kanaskie
Susan J. Loeb
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2015
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0387-x

Weitere Artikel der Ausgabe 3/2015

Journal of Cancer Survivorship 3/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.